SEC Tracker
Get the app
MBOT · XBRL financial data

Microbot Medical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (MBOT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers——————————105241
Cost of revenue——————————103884
Gross profit——————————2(643)
Research and development1,6121,130*1,1691,4172,0601,984*1,4592,1111,1711,542*1,2931,861
Selling, general and administrative—————year only1,5621,612—year only3,0293,684
General and administrative932938*1,2151,0941,2401,446*1,5621,6122,690———
Operating income (loss)(2,544)(2,068)*(2,384)(2,511)(3,300)(3,430)*(3,021)(3,723)(3,861)(4,138)*(4,320)(6,188)
Other income (expense)——————3160*0*———
Net income (loss)(2,446)(3,154)*(2,371)(2,465)(3,215)(3,392)*(2,601)(3,500)(3,577)(3,464)*(3,671)(5,627)
Earnings per share, basic USD per share(0.21)(0.27)*(0.17)(0.17)(0.20)(0.20)*(0.08)(0.10)(0.07)—(0.05)(0.08)
Earnings per share, diluted USD per share(0.21)(0.27)*(0.17)(0.17)(0.20)(0.20)*(0.08)(0.10)(0.07)—(0.05)(0.08)
Weighted average shares, basic thousands of shares11,70711,822*14,05614,84716,47117,178*31,08636,48848,095—67,15867,164
Weighted average shares, diluted thousands of shares11,70711,822*14,05614,84716,47117,178*31,08636,48848,095—67,15867,164
  • † Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (MBOT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents1,3352,4681,1622,4654793,1143,2174,0826,7043,9123,6573,152
Marketable securities6,8183,9175,1873,9973,8592,35627,17328,59273,45474,68068,84364,215
Accounts receivable——————————105176
Inventory—————————5842,2572,907
Prepaid and other current assets208152603628609300218164573644660709
Total current assets8,4077,9217,0007,1384,9955,81930,65632,89180,78579,82276,52872,173
Property and equipment, net184146132122998078757893188316
Right-of-use asset297260235174114132158165897833870800
Total assets8,8888,3277,3677,4345,2086,03130,89233,13181,76081,54478,06673,365
Accounts payable238357961782461651865035095111,085871
Accrued liabilities1,0471,0278961,0531,0602,2251,6172,1222,1282,6141,9782,691
Total current liabilities1,4913,7861,1831,3411,3712,4601,8932,7272,9343,4213,3873,888
Lease liability, non-current3940173829414847602569574550
Total liabilities1,5303,8261,2001,3791,4002,5011,9412,7743,5363,9903,9614,438
Accumulated deficit(76,347)(79,501)(81,872)(84,337)(87,552)(90,944)(93,545)(97,045)(100,622)(104,086)(107,757)(113,384)
Total stockholders' equity7,3584,5016,1676,0553,8083,53028,95130,35778,22477,55474,10568,927
Total liabilities and equity8,8888,3277,3677,4345,2086,03130,89233,13181,76081,54478,06673,365
Common shares outstanding (cover page) thousands of shares11,70714,39914,39916,50416,93234,74436,37845,54667,15867,15867,16567,165
  • † Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (MBOT's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024†Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(2,446)(3,154)*(2,371)(2,465)(3,215)(3,392)*(2,601)(3,500)(3,577)(3,464)*(3,671)(5,627)
Stock-based compensation336*297*453331*283*282*256237328*236*222433
Depreciation and amortization20*35*2814*23*26*1512*10*10*1215*
Net cash from operating activities(1,655)*(1,821)*(2,420)(1,957)*(2,759)*(1,691)*(2,874)(2,573)*(3,841)*(3,758)*(5,053)(4,989)*
Purchases of property and equipment28*(5)*144*0*7*139*13*25*108142*
Net cash from investing activities(2,572)*2,957*(1,284)1,186*140*1,495*(24,830)(1,309)*(44,712)*(1,533)*4,9974,471*
Proceeds from issuing equity(161)*0*2,3972,074*633*2,832*27,8064,752*—year only——
Net cash from financing activities(161)*0*2,3972,074*633*2,832*27,8064,752*51,176*2,506*——
Net change in cash(4,388)*1,136*(1,307)1,303*(1,986)*2,636*102870*2,623*(2,785)*(56)(502)*
  • † Share count changed about 2x in the period ending 2024-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Microbot Medical3,152241(4,989)*67.2M13.5 quarters 10-QJun 30, 2026
Fonar53,65026,4721,580*not reported— 10-QMar 31, 2026
Pulmonx52,69022,835(3,183)*43.6M8.5 quarters 10-QSep 30, 2026
Accuray40,623100,919*2,427*119.4M— 10-KJun 30, 2026
Lucid Diagnostics33,404not reported(11,297)*203.2M3.0 quarters 10-QJun 30, 2026
TriSalus Life Sciences46,28811,407(10,129)*61.6M4.6 quarters 10-QJun 30, 2026
CVRx64,58615,705(8,826)*26.6M7.3 quarters 10-QJun 30, 2026
LENSAR13,56516,495(127)*12.3M106.8 quarters 10-QJun 30, 2026
Apyx Medical27,61713,884(3,490)*42.1M7.9 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.